AGL Company Profile and Key Details

AGL has shown mixed momentum, losing -0.98% over the past week and 1.75% over the past quarter, though year-to-date performance is up 41.82%. Short-term trend indicators are bullishly aligned (SMA20 8.49%, SMA50 -17.03%, SMA200 -52.96%). The stock’s 14-day RSI is 50.76 (neutral), while the ATR of 0.07 points to tighter daily ranges. The stock remains sitting in the mid-range of its 52-week band, trading -90.26% below its high and over 75.47% above its low. Average 10-day trading volume of 302.60 thousand shares is below the 3-month average of 338.72 thousand, indicating normal recent market interest.

Agilon Health, Inc. has 16.79 million shares outstanding. The public float is 9.80 million shares, elevated short interest at 8.25% of float. This equals 859.44 thousand shares. The short ratio is 2.61 days. Institutional investors hold 95.71% of the float. Insiders own 3.16%. CD&R Vector Holdings, L.P. holds 194.61 million shares, CD&R Investment Associates IX, Ltd. has 100.00 million shares and Shaker Benjamin has 1.37 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Agilon Health, Inc. (NYSE:AGL) closed at $97.18 USD, gaining $1.78 (1.87%) from the previous close of $95.40. The stock is currently mid-range between its 52-week high and low $7.48 and $133.04. With a market capitalization of about $1.62 billion, Agilon Health, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~3.05). Key stats such as the average daily volume over the past year has been around 340.53 thousand shares, volume is running light vs its 52-week average. Headquartered in Westerville, OH, Agilon Health, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Timothy O'Rourke, the company employs approximately 856 people and listed since April 15, 2021. Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States.

Agilon Health, Inc. trades at a P/E ratio of -6.34, slightly below the S&P 500 average, with a price-to-sales ratio of 0.27 and a price-to-book ratio of 7.16 trading at moderately above to book value. The P/FCF stands at -14.48, also below market averages.

Agilon Health, Inc. last paid a dividend of 1.8 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Agilon Health, Inc. (NYSE:AGL) shares are up 41.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Agilon Health, Inc. trading at a premium to the broader market with a P/E of -6.34. Analyst sentiment is cautious, with the majority of ratings in Sell territory and a mean price target of $24.53, suggesting -74.29% downside. Our AI forecast model points to short-term weakness (-10.59% over two weeks), a medium-term rise (34.75% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Agilon Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.59%, with price expected at $85.30 by September 01, 2026, within a range of $74.54 to $95.75 3-Month Outlook: Projected rise of 34.75%, reaching $128.55 by November 16, 2026, with a range of $125.73 to $131.59. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by August 18, 2027, within a range of $0.00 to $9.35.